Streichenberg acted as legal counsel to Valora, the foodvenience provider in Switzerland, in its takeover of the operation of 39 Moveri petrol station shops on January 1, 2022. Moveri operates around 530 service stations in Switzerland, both for its own brands Ruedi Rüssel and Miniprix, and for the international brands BP and Shell. […]
Baker McKenzie Switzerland advised Datwyler, the provider of high-quality, system-critical elastomer components, on its sale of the online distributor Reichelt to private equity firm, Invision. The sale of Reichelt is due to be completed in
Lenz & Staehelin advised global investment firm KKR and the heirs of Patrick Winter on a share sale and placement of approximately 8.6 million shares in SoftwareOne Holding, the provider of end-to-end software and cloud technology
Eversheds Sutherland advised Mekatrade Asia Singapore and CI Resources, Australia, with regard to a transaction to acquire a 50% stake in Kemoil, a Geneva based oil-products trading company, for a commitment of approximately CHF 5 million. Kemoil
Niederer Kraft Frey advised the Ironman Group, an operator of mass participation sports in the world, on the acquisition of premier multi-day cycling event series Haute Route as well as the Gravel Epic, a soon-to-launch
Novaremed, a privately held clinical-stage biopharmaceutical company, expands its pipeline of non-opioid treatment candidates for chronic pain indications through the acquisition of Metys Pharmaceuticals. The acquisition broadens Novaremed’s existing pipeline by adding both
The insurer Zurich Switzerland, a Swiss subsidiary of the Zurich Insurance group, has acquired a 25% stake in the share capital of Brokerbusiness.ch., an insurtech start-up that operates a digital insurtech
Baker McKenzie advised Amsterdam-based Keesing Media Group (Keesing) on the acquisition of the Swiss Küng Group. The deal will enable Keesing to to strengthen its European market presence and develop a stronger foothold in
The Deutsche Börse Group, an international exchange organisation and innovative market infrastructure provider, acquires a majority of the shares in Crypto Finance, a Swiss crypto broker and asset manager. Through the acquisition, Deutsche Bö
EnBiotix, a Boston-based biotech company focused on rare diseases, is merging with Swiss oncology and antimicrobial resistance-focused company Polyphor. A merger agreement under which Polyphor will use all of EnBiotix’s outstanding share capital in
